article Open AccessTop 1% cited

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

Intensive Care Medicine · 2020 · Vol. 46(6) · pp. 1089–1098

Julie Helms✉(Université de Strasbourg)Charles Tacquard(Hôpital Civil, Strasbourg)François Séverac(Hôpitaux Universitaires de Strasbourg)Ian Léonard-Lorant(Hôpital Civil, Strasbourg)Mickaël Ohana(Hôpital Civil, Strasbourg)Xavier Delabranche(Hôpital Civil, Strasbourg)Hamid Merdji(Inserm)Raphaël Clère-Jehl(Inserm)M. Schenck(Hôpitaux Universitaires de Strasbourg)Florence Fagot Gandet(Hôpitaux Universitaires de Strasbourg)Samira Fafi‐Kremer(Hôpitaux Universitaires de Strasbourg)Vincent Castelain(Hôpitaux Universitaires de Strasbourg)Francis Schneider(Hôpitaux Universitaires de Strasbourg)L. Grunebaum(Hôpitaux Universitaires de Strasbourg)Eduardo Anglés‐Cano(Université Paris Cité)Laurent Sattler(Hôpitaux Universitaires de Strasbourg)Paul‐Michel Mertès(Hôpital Civil, Strasbourg)Ferhat Meziani(Inserm)

View via DOI Full-text PDF

COVID-19 Clinical Research Studies Long-Term Effects of COVID-19 Venous Thromboembolism Diagnosis and ManagementMedicineARDSInternal medicineDisseminated intravascular coagulationProspective cohort studyThrombosisIntensive careCoagulopathyLungIntensive care medicine

MeSH terms

BetacoronavirusCOVID-19SARS-CoV-2AgedAnticoagulantsFemaleFibrin Fibrinogen Degradation ProductsFranceHumansIntensive Care UnitsMaleMiddle AgedPneumonia, ViralProspective StudiesPulmonary Embolism

Citations

2,889

FWCI

66.99

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Thrombotic complications of COVID-19 and its relation with NADPH oxidase and tissue factor